Research & Discoveries

Explore groundbreaking studies and latest advancements in biochemistry

Research Articles

Small Molecule vs. Peptidomimetic SH2 Domain Inhibitors: A Strategic Comparison for Targeted Drug Discovery

This article provides a comprehensive comparison for researchers and drug development professionals on two primary strategies for inhibiting SH2 domain-mediated protein-protein interactions: small molecules and peptidomimetics.

Harper Peterson
Dec 02, 2025

STAT1 vs STAT3 SH2 Domain Specificity: Structural Insights, Inhibitor Design, and Therapeutic Implications

This review provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains of STAT1 and STAT3, transcription factors critical in immunity, inflammation, and cancer.

Christian Bailey
Dec 02, 2025

Overcoming Compensatory Signaling in STAT Pathway Inhibition: Mechanisms and Combination Therapies

Constitutive activation of the JAK-STAT pathway is a hallmark of numerous cancers and autoimmune diseases, driving the development of targeted inhibitors.

Natalie Ross
Dec 02, 2025

Breaking the Barrier: Strategies for Enhancing Cellular Uptake of SH2 Domain-Targeted Therapeutics

Targeting Src Homology 2 (SH2) domains represents a promising therapeutic strategy for modulating dysregulated cell signaling in cancer and other diseases.

Ellie Ward
Dec 02, 2025

Mastering SH2 Domain Dynamics: Strategies for Managing Rapid Off-Rates in Phosphopeptide Interactions

This article provides a comprehensive analysis of rapid off-rates in SH2 domain-phosphopeptide interactions, a critical feature for ensuring dynamic and specific cellular signaling.

Robert West
Dec 02, 2025

Beyond the Shallow Surface: Innovative Strategies for Targeting SH2 Domains in Drug Discovery

Targeting the shallow binding surfaces of Src Homology 2 (SH2) domains represents a significant challenge and opportunity in therapeutic development, particularly for cancer and neurodegenerative diseases.

Lillian Cooper
Dec 02, 2025

Conquering Flexibility: Advanced Strategies for Targeting STAT SH2 Domains in Drug Design

The Signal Transducer and Activator of Transcription (STAT) proteins are critical transcription factors whose dysregulation drives numerous diseases, particularly cancer.

Noah Brooks
Dec 02, 2025

Troubleshooting STAT Dimerization Assays: A Comprehensive Guide for Cellular Systems Research

This article provides researchers, scientists, and drug development professionals with a comprehensive framework for understanding, performing, and troubleshooting STAT protein dimerization assays in cellular systems.

Mason Cooper
Dec 02, 2025

Optimizing SH2 Domain Structural Models for Enhanced Virtual Screening in Drug Discovery

This article provides a comprehensive guide for researchers and drug development professionals on optimizing SH2 domain structural models to improve the success rate of virtual screening.

Lucy Sanders
Dec 02, 2025

Targeting the Distinction: Strategies for Achieving Selectivity Between STAT and Src-Family SH2 Domains in Drug Discovery

This article provides a comprehensive analysis of the strategies and challenges in achieving high selectivity between the SH2 domains of STAT and Src-family kinases (SFKs), a critical goal for developing...

Christopher Bailey
Dec 02, 2025

Popular Articles

Research Tags